FindTrial
Sign In

Understanding the basis of reduced incidence of skin cancers in vitiligo and understanding the role of MALAT-1

Understanding the molecular basis of reduced incidence of skin cancers in vitiligo: deciphering the role and regulation of long- non coding RNA- MALAT-1

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/04/065885
Enrollment
30
Registered
2024-04-18
Start date
Unknown
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L80- Vitiligo

Interventions

Intervention1: nil: nil Control Intervention1: nil: nil

Sponsors

Dr. D.Y. Patil Medical College, Hospital and Research centre,, Pune
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients diagnosed with stable (6months) non-segmental vitiligo

Exclusion criteria

Exclusion criteria: Pregnant or lactating women Active infection Suffering from other autoimmune diseases

Design outcomes

Primary

MeasureTime frame
To investigate the reduced incidence of skin cancers in vitiligoTimepoint: 2years—

Secondary

MeasureTime frame
understand the role of MALAT-1 in development of skin cancers in vitiligoTimepoint: 2 years—

Countries

India

Contacts

Public ContactDr Namratha Puttur

Dr. D.Y. Patil Medical College, Hospital and Research centre

putturnamratha@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026